Why Viking Therapeutics Stock Popped Today

2025 is the year we learn whether Viking Therapeutics stock will be a winner.Viking Therapeutics (VKTX -1.08%) stock inched 2.3% higher through 10:20 a.m. ET Monday, and for a most curious reason.Truist Securities analyst Joon Lee just lowered his price target on the unprofitable biotech stock. Now why would investors think this is good news for Viking?Truist's backhanded compliment for Viking TherapeuticsThe theory goes like this: Lee cut his price target on Viking from $95 to$75 a share, warning the comp ...